Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 4,991 | 7,031 | 10,737 | 17,041 | 12,293 | 14,868 | 11,560 |
| EBITDA | -16 | -144 | 642 | 6 | 1,329 | 6,730 | 4,397 |
| Net profit | -142 | -1,075 | 1,369 | 161 | 1,242 | 6,774 | 4,159 |
| Total assets | 5,420 | 7,041 | 14,172 | 13,365 | 9,629 | 12,176 | 12,125 |
| n (companies reporting) | 2 | 3 | 4 | 4 | 4 | 4 | 4 |
GEL, thousands
| Company | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Alpaparm | — | 0 | 2,385 | 2,416 | 2,980 | 3,488 | 2,960 |
| Milana 2022 | — | — | — | — | 0 | 6,650 | 2,943 |
| H Bi-Georgia | 4,991 | 4,898 | 5,621 | 8,939 | 6,782 | 2,353 | 2,844 |
| Prime line | — | — | 0 | 2,819 | 2,531 | 2,378 | 2,814 |
| Ermed Georgia | 0 | 2,133 | 2,731 | 2,867 | — | — | — |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2018–FY2024 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.